---
$id: https://graph.org.ai/products/commodity/51143005
$type: Product
source: UNSPSC
code: "51143005"
title: "Brivaracetam"
class: "51143000"
classTitle: "Nootropics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Brivaracetam

**UNSPSC Code**: 51143005
**Class**: [Nootropics](Nootropics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuroprotective agent and anticonvulsant agent with the molecular formula C11H20N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, U863JGG2IA chemically known as 1-pyrrolidineacetamide, .alpha.-ethyl-2-oxo-4-propyl (.alpha.s,4r)- but generally known as brivaracetam, which bears US NIH Compound Identifier 9837243. European Medicines Agency schedules Brivaracetam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25397. The term BRIVARACETAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 1, 2006, list 55). Most nations schedule brivaracetam under HS 29337900 and SITC 51561. As of Q4 2014, BRIVARACETAM remains the US FDA Preferred Term for this commodity. Brivaracetam bears US NLM identifiers UMLS ID C1699861 and NCI Concept Code C65270. SMILES: CCCC1CC(=O)N(C1)C(CC)C(=O)N.

